CoChat

The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus

Niznik, Hyman B., Fogel, Evan F., Fassos, Frank F., Seeman, Philip · 1991 · Journal of Neurochemistry
Cited by 154

The DOI matches its Crossref record.

Abstract

The neuronal dopamine transporter/uptake site can be covalently labeled with the photoaffinity probe 1‐(2‐[bis‐(4‐fluorophenyl)methoxy]ethyl)‐4‐[2‐(4‐azido‐3‐[125 I]iodophenyl)ethyl]piperazine ([125 I]FAPP) and visualized following sodium dodecyl sulfate polyacrylamide gel electrophoresis and autoradiography. Upon photolysis, [125 I]FAPP specifically incorporated into a polypeptide of apparent M r= 62,000 in membranes from both the putamen and the caudate nucleus of control, Alzheimer's, schizophrenia, and Huntington's diseased brain, and, following complete deglycosylation, migrated as an M r∼48,000 polypeptide. In parkinsonian postmortem putamen, however, there was no detectable photoincorpqration of [125 I]FAPP into the ligand binding subunit of the dopamine transporter. [125 I]FAPP did specifically label the Mr 62,000 polypeptide of parkinsonian caudate, although with efficiencies of 20–50% of control. The asymmetrical loss of the dopamine transporter in Parkinson's diseased striatum was confirmed in reversible receptor binding experiments using [3 H]GBR‐12935 {3 H‐labeled 1‐[2‐(diphenylmethoxy)ethyl]‐4‐(3‐phenylpropyl)piperazine}. In parkinsonian putamen, mazindol competitively inhibited the binding of [3 H]GBR‐12935 with an estimated affinity (Ki∼ 2,000 n M) 10 times lower than in controls (Ki∼ 30 n M), while the affinity of mazindol for [3 H]GBR‐12935 binding in the caudate was equal to that seen with controls (Ki∼ 50 n M). The proportion of [3 H]GBR‐12935 binding sites recognized by mazindol with high affinity in Parkinson's diseased caudate was, however, reduced by 50–80%. Taken together, these data clearly suggest that (a) the dopamine transporter is not detectable in Parkinson's diseased putamen, (b) [3 H]GBR‐12935 binding in the putamen of Parkinson's diseased brain is probably not to the dopamine uptake carrier, and (c) there is an interregional variation in the loss of dopamine uptake sites (lost in putamen and somewhat spared in caudate), which appears to parallel markedly the reported loss of dopamine content in idiopathic Parkinson's diseased striatum.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1991.tb02580.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 154

Metadata

Authors
Niznik, H. B., Fogel, E. F., Fassos, F. F., & Seeman, P.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
1991-01
Volume
56
Issue
1
Pages
192-198
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2063242294
Cited by
154
References
0
FWCI
5.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus. https://app.cochat.ai/papers/10.1111/j.1471-4159.1991.tb02580.x
The paper
Niznik, H. B., Fogel, E. F., Fassos, F. F., & Seeman, P. (1991). The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1991.tb02580.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.